FutureChem Announces Rights Offering and Stock Dividend: 15.1% Dilution for 40B Won Operating Funds and 20% Stock Dividend, Total Shares Increase by 35.1%

Rights offering: 3,389,830 new common shares (15.1% increase from current), estimated issue price of 11,800 won (25% discount), raising approximately 40 billion won for operating funds. Record date July 16, 2026; existing shareholders receive 0.15118 shares per share held.
Stock dividend: After the rights offering, 5,163,450 additional common shares are distributed at a ratio of 0.2 per share, increasing total common shares to 30,980,700 (30,986,972 including treasury). Record date September 18, 2026.
The proceeds are for general operating funds, not specific facility investment or M&A, indicating a liquidity-driven motive rather than growth-oriented use.
Dilution: The rights offering dilutes existing shareholders by 15.1%. The stock dividend is proportional and does not change ownership percentages, but the increased share count may pressure EPS and stock price.
[AI Analysis]This combined offering addresses short-term funding needs but lacks clear growth purpose, likely perceived negatively by investors. The significant increase in total shares is expected to exert downward pressure on the stock price, raising concerns about shareholder value dilution.